Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Ganetespib
Sponsor: Dana-Farber Cancer Institute